Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Japan Olympic adviser urges COVID-19 vaccine option for athletes

Published 04/13/2021, 01:46 AM
Updated 04/13/2021, 02:36 AM
© Reuters. FILE PHOTO: Man looks at his mobile phone next to The Olympic rings in front of the Japan Olympics Museum in Tokyo

By Rocky Swift

TOKYO (Reuters) - A health adviser to Japan's Olympic committee said on Tuesday athletes should have the option of getting COVID-19 vaccines, days after public outcry led the government to deny it was making them a priority.

Japan on Thursday had dismissed a media report that it was considering vaccinating all its Olympians by the end of June after the idea sparked a social media uproar amid a slow vaccine rollout for the rest of the population.

But on Tuesday, the adviser, Nobuhiko Okabe, told Reuters that although vaccines should not be an obligation, they should be available to the athletes who want them. Okabe is an infectious disease expert who helped guide Japan's response to the H1N1 outbreak in 2009 and advises on its COVID-19 response.

"I think the recommendation should be to be immunized, particularly for the athletes," said Okabe, who has held leadership roles in the World Health Organisation.

He said choices by individual athletes to refuse the vaccine for health or religious reasons "should be respected."

About 1.1 million health care workers in Japan have received at least their first dose of Pfizer (NYSE:PFE) Inc-BioNTech's vaccine.

Inoculations of the country's sizable elderly population began on Monday, but some experts caution that shots for the general populace may not be available until late summer or even winter because of constrained supplies.

Okabe, who heads the Kawasaki City Institute for Public Health, also said Japan's commercialisation and licensing hurdles involving drugs and medical products remain a "big problem," as they could slow its response to health crisis such as pandemics.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Japan has approved only one COVID-19 vaccine so far and about 0.9% of its population of 126 million has gotten at least one dose of COVID-19 vaccine, compared with 2.2% in South Korea or 36% in the United States, according to a Reuters tracker.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.